New trends in parathyroid scintigraphy

European Journal of Nuclear Medicine

Volumn 28, Issue 9, 2001, Pages 1409-1420

  Giordano, Alessandro ^a   Rubello, Domenico ^b   Casara, Dario ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

99mTc sestamibi; 99mTc tetrofosmin; Cost effectiveness; Minimally invasive radio guided surgery; Parathyroid scintigraphy; Unilateral neck exploration

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HYPERPARATHYROIDISM; MINIMALLY INVASIVE SURGERY; PARATHYROID SCINTISCANNING; RELIABILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOMA; COST-BENEFIT ANALYSIS; HUMANS; HYPERPARATHYROIDISM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034890296     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100596     Document Type: Article

References (95)

1. NIH conference: Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement
2. Parathyroid scanning with selenium-75 labeled methionine
3. Selective isotopic labeling of the human parathyroid: A preliminary case report
4. 201T1
5. New perspectives in localising enlarged parathyroids by technetium-thallium subtraction scan
6. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study)
7. 99mTc sestamibi parathyroid scintigraphy
8. Localization of parathyroid enlargement: Experience with technetium 99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasound and computed tomography
9. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123
10. 99mTc-sestamibi gamma probe technique in planning unilateral and minimally invasive surgery in primary hyperparathyroidism
11. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile
12. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery
13. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements
14. Parathyroid adenomas without sestamibi retention
15. Rapid wash-out of technetium-99m-MIBI from a large parathyroid adenoma
16. 99mTc sestamibi scanning and intraoperative quick parathormone assay
17. 99mTc-sestamibi - A new agent for parathyroid imaging
18. Parathyroid imaging with technetium-99m-sestamibi: Preoperative localization and tissue uptake studies
19. 99mTc-MIBI
20. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy. A fast and effective technique
21. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging
22. Prospective evaluation of the efficacy of technetium-99m-sestamibi and iodine-123 radionuclide imaging of abnormal parathyroid glands
23. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination of Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans
24. Radionuclide parathyroid imaging
25. Parathyroid imaging with technetium-99m labelled cationic complexes: Which tracer and which technique should be used?
26. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT
27. 99mTc-sestamibi) imaging of the parathyroid glands in patients with renal failure
28. Preoperative imaging of parathyroid glands
29. Parathyroid scintigraphy: First experiences with technetium(III)-99m-Q12
30. 201thallium
31. Parathyroid imaging with Tc99m-tetrofosmin
32. Detection of an intrathymic parathyroid adenoma by Tc-99m tetrofosmin: Comparison with T1-201
33. Radionuclide parathyroid imaging
34. Technetium-99m-tetrofosmin for parathyroid scintigraphy: A comparison with sestamibi
35. Techntium-99m-tetrofosmin for parathyroid scintigraphy: Comparison to thallium-technetium scanning
36. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands
37. 99mTc-tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands
38. 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area
39. Reduced thyroid uptake and slower wash-out of tetrofosmin as compared to sestamibi in 64 normal subjects: An explanation of differences in parathyroid scintigraphy
40. 99mTc-sestamibi in parathyroid scintigraphy. Results in 133 subjects
41. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging
42. Technetium-99m sestamibi parathyroid scintigraphy: Effect of P-glycoprotein, histology and tumor size on detectability
43. Preoperative localization of parathyroid lesions in hyperparathyroidism: Relationship between technetium-99m MIBI uptake and oxyphil cell content
44. 99mTc-sestamibi uptake and oxyphil cell content in hyperparathyroidism?
45. 99mTc-MIBI scan: Semiquantitative analysis correlated with histologic findings
46. Pre-operative localization and tissue uptake study in parathyroid imaging with technetium-99m-sestamibi
47. (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism
48. Parathyroid imaging
49. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy
50. Technetium-99m-tetrofosmin parathyroid imaging: Results with double-phase study and SPECT in primary and secondary hyperparathyroidism
51. 99mTc-sestamibi subtraction SPECT in hyperparathyroidism
52. Technetium-99m-sestamibi dual-phase SPECT imaging: Concordance with ultrasound
53. Preoperative imaging of parathyroid glands
54. Iterative reconstruction: An improvement of technetium-99m-MIBI SPECT for the detection of parathyroid adenoma?
55. Comparison and histopathological correlation of three parathyroid imaging methods in a population with high prevalence of concomitant thyroid diseases
56. 99mTc-sestamibi en un paciente afecto de un carcinoma laringeo y de un adenoma paratiroideo
57. 4/MIBI) in primary hyperparathyroidism
58. Intraoperative assessment of parathyroid gland pathology. A common review from the surgeon and the pathologist
59. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure
60. Procedure guideline for parathyroid scintigraphy
61. Unilateral parathyroidectomy in hyperparathyroidism due to a single adenoma
62. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests
63. Technetium-99m-sestamibi parathyroid localization is accurate enough for scan-direct unilateral neck exploration
64. Unilateral surgery for primary hyperparathyroidism on the basis of technetium-99m sestamibi and iodine-123 subtraction scanning
65. Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay
66. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping
67. Minimally invasive radioguided parathyroidectomy: An endocrine surgeon's perspective
68. 99mTc-MIBI and ultrasound imaging protocol
69. A new approach to parathyroidectomy
70. Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of PTH for unilateral neck exploration of primary hyperparathyroidism
71. Preoperative technetium-99m-sestamibi imaging: Paving the way to minimal access parathyroid surgery
72. Surgical management of hyperparathyroidism in view of a reliable parathyroid adenoma localization test
73. Preoperative localization in unilateral parathyroid surgery. A cost-benefit study on ultrasound, computed tomography and scintigraphy
74. Unilateral parathyroidectomy: The value of the localizing scan
75. Correct preoperative localization: Does it permit a change in operative strategy for primary hyperparathyroidism?
76. Hyperparathyroid and hypoparathyroid disorders
77. Preoperative imaging of parathyroid glands with technetium-99m-sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism
78. Double-phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism
79. Preoperative parathyroid gland localization with technetium-99m-sestamibi in secondary hyperparathyroidism
80. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure
81. Parathyroid ultrasonography
82. Diagnostic imaging in primary hyperparathyroidism. Radiological techniques: US - CAT - MR
83. Color Doppler sonography in the detection of parathyroid adenomas
84. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound, and MRI for localization of abnormal parathyroid glands
85. High-resolution ultrasonography: Highly sensitive specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease
86. Use of color and power Doppler sonography to identify feeding arteries associated with parathyroid adenomas
87. Monitoring treatment response with color and power Doppler
88. MR imaging of abnormal parathyroid glands
89. 99mTc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands
90. Preoperative MR imaging in hyperparathyroidism: Results and factors affecting parathyroid detection
91. 99mTc-MIBI scintigraphy and US for demonstration of parathyroid glands and nodules
92. Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism
93. Technetium 99m-tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism
94. Techetium-99m-sestamibi, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism
95. 99mTc-MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism